Research field (2):
Clinical pharmacy
, Physiology
Research keywords (3):
bone and mineral
, osteoarthritis
, cartilage
Research theme for competitive and other funds (1):
2015 - 2017 変形性関節症の病態制御機構における組織線溶系の役割の解明
Papers (14):
T. Minashima, K. A. Campbell, S. R. Hadley, Y. Zhang, T. Kirsch. The role of ANK interactions with MYSBP1a and SPHK1 in catabolic events of articular chondrocytes. OSTEOARTHRITIS AND CARTILAGE. 2014. 22. 6. 852-861
Minashima T, Campbell K, Kirsch T. Annexins: novel therapeutic targets for the treatment of osteoarthritis?. The Journal of the American Academy of Orthopaedic Surgeons. 2013. 21. 4. 256-257
Minashima T, Zhang Y, Lee Y, Kirsch T. LITHIUM CHLORIDE - A NOVEL TREATMENT FOR OSTEOARTHRITIS?. Osteoarthritis & Cartilage. 2013. 21. S233
he Role Of Ank Interactions With Mybbp1a And Sphk1 In Catabolic Events Of Articular Chondrocytes.
(Annual Meeting of the Orthopaedic Research Society 2014)
The role of ank in catabolic events of articular chondrocytes.
(Osteoarthritis Research Society International World Congress 2014)
LITHIUM CHLORIDE - A NOVEL TREATMENT FOR OSTEOARTHRITIS?
(Osteoarthritis Research Society International World Congress 2013)
ANNEXIN A6: A NOVEL THERAPEUTIC TARGET FOR THE TREATMENT OF OSTEOARTHRITIS?
(Osteoarthritis Research Society International World Congress 2013)
he Role of the Progressive Ankylosis Protein (ANK) in Bone Fracture Healing.
(Annual Meeting of the Orthopaedic Research Society 2012)